Adjusted EBITDA margin target maintained at 19% for FY22, +100bps YoY. but above consensus estimates (Cons: 5.8%). Miss in revenue was led by to flattish growth in insurance vertical because of delayed Advantage Go license realization which is expected to bounce back in Q3 aiding both...